Progyny Stock Forecast
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PGNY analyst consensus
Consensus (12 analysts)
none
Avg. price target
$34.42+24.94%
- Strong buy 1
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Progyny (2026-10-07), 10 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $34.42, with a high estimate of $40.00 and a low estimate of $30.00. The average target implies upside of 24.9% from the current price of $27.55.
The spread between the highest and lowest targets is 33.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PGNY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 8% |
| Buy | 9 | 75% |
| Hold | 2 | 17% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $30.00 | +8.89% |
| Average target | $34.42 | +24.94% |
| High target | $40.00 | +45.19% |